Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
deals
investing
2
×
life sciences
national blog main
san francisco
2
×
san francisco blog main
san francisco top stories
10x genomics
amgen
biotech ipos
boston blog main
boston top stories
cancer
cancer drugs
cobimetinib
desmoid tumors
dihydroergotamine
generic drugs
ipo
medical device
national top stories
new york blog main
new york top stories
nirogacestat
pfizer
rare diseases
renaissance capital
revolution medicines
roche
sanofi
satsuma pharmaceuticals
springworks therapeutics
startups
the column group
third rock ventures
university of illinois
venture capital
warp drive bio
What
ipo
2
×
biotech
boost
cancer
companies
despite
drug
family
followed
genomics
hardest
haul
hit
hottest
hunters
led
life
markets
medicines
proteins
public
ras
reels
research
revolution
satsuma
science
springworks
street
targets
wall
way
wednesday
week
week’s
welcomed
Language
unset
Current search:
investing
×
ipo
×
" san francisco "
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
